drugset / Trial / NCT00723424

Drug Interaction Study - Effect of AZD5672 on the Pharmacokinetics of Digoxin

NCT00723424

Phase 1 Completed 24 enrolled AstraZeneca
Non-randomizedSingle-groupOpen-labelBasic science

Summary

The purpose of the study is to examine the effect of AZD5672 (dosed to steady state) on the pharmacokinetics of digoxin (single dose administration).

Timeline

Start
2008-07
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD5672 Small molecule 50 mg
Subject Digoxin Other / unclassified 0.5 mg

Indications

No indication recorded.